SLEEP NUMBER CORP (SNBR) Fundamental Analysis & Valuation

NASDAQ:SNBR • US83125X1037

Current stock price

3.45 USD
-0.22 (-5.99%)
At close:
3.45 USD
0 (0%)
After Hours:

This SNBR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SNBR Profitability Analysis

1.1 Basic Checks

  • In the past year SNBR has reported negative net income.
  • In the past year SNBR has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: SNBR reported negative operating cash flow in multiple years.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

  • SNBR has a Return On Assets of -10.42%. This is in the lower half of the industry: SNBR underperforms 73.39% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.59%, SNBR is in line with its industry, outperforming 54.03% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SNBR is significantly below the industry average of 13.58%.
  • The last Return On Invested Capital (3.59%) for SNBR is well below the 3 year average (7.69%), which needs to be investigated, but indicates that SNBR had better years and this may not be a problem.
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROIC 3.59%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.35%, SNBR is in line with its industry, outperforming 47.58% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SNBR has declined.
  • SNBR has a Gross Margin of 60.05%. This is amongst the best in the industry. SNBR outperforms 88.71% of its industry peers.
  • SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 60.05%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SNBR Health Analysis

2.1 Basic Checks

  • SNBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • SNBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • SNBR has an Altman-Z score of -0.15. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.15, SNBR is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.15
ROIC/WACC0.46
WACC7.74%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

  • SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SNBR has a Current ratio of 0.19. This is amonst the worse of the industry: SNBR underperforms 94.35% of its industry peers.
  • A Quick Ratio of 0.09 indicates that SNBR may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.09, SNBR is doing worse than 93.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.09
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. SNBR Growth Analysis

3.1 Past

  • SNBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -472.22%.
EPS 1Y (TTM)-472.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-828.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.81%

3.2 Future

  • SNBR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.64% yearly.
  • The Revenue is expected to grow by 1.98% on average over the next years.
EPS Next Y90.49%
EPS Next 2Y44.4%
EPS Next 3Y30.64%
EPS Next 5YN/A
Revenue Next Year-1.9%
Revenue Next 2Y2.12%
Revenue Next 3Y1.98%
Revenue Next 5YN/A

3.3 Evolution

SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. SNBR Valuation Analysis

4.1 Price/Earnings Ratio

  • SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SNBR is valued cheaply inside the industry as 98.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.99
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • SNBR's earnings are expected to grow with 30.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.4%
EPS Next 3Y30.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SNBR Dividend Analysis

5.1 Amount

  • No dividends for SNBR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SNBR Fundamentals: All Metrics, Ratios and Statistics

SLEEP NUMBER CORP

NASDAQ:SNBR (3/13/2026, 8:00:02 PM)

After market: 3.45 0 (0%)

3.45

-0.22 (-5.99%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-12
Earnings (Next)04-28
Inst Owners84.44%
Inst Owner Change-6.24%
Ins Owners6.37%
Ins Owner Change4.71%
Market Cap78.63M
Revenue(TTM)N/A
Net Income(TTM)-78.11M
Analysts48.89
Price Target11.22 (225.22%)
Short Float %29.04%
Short Ratio7.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-915.82%
Min EPS beat(2)-937.57%
Max EPS beat(2)-894.07%
EPS beat(4)1
Avg EPS beat(4)-818.76%
Min EPS beat(4)-1452.29%
Max EPS beat(4)8.9%
EPS beat(8)3
Avg EPS beat(8)-410.77%
EPS beat(12)5
Avg EPS beat(12)-256.42%
EPS beat(16)7
Avg EPS beat(16)-175.27%
Revenue beat(2)0
Avg Revenue beat(2)-8.66%
Min Revenue beat(2)-10.05%
Max Revenue beat(2)-7.26%
Revenue beat(4)0
Avg Revenue beat(4)-6.41%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.76%
Revenue beat(12)1
Avg Revenue beat(12)-4.74%
Revenue beat(16)3
Avg Revenue beat(16)-4.59%
PT rev (1m)22.22%
PT rev (3m)100%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.39%
EPS NY rev (1m)0%
EPS NY rev (3m)0.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 0.99
EPS(TTM)-5.15
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-2.06
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS63.22
BVpS-22.88
TBVpS-25.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROCE -13.07%
ROIC 3.59%
ROICexc 3.6%
ROICexgc 4.25%
OM 1.35%
PM (TTM) N/A
GM 60.05%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexgc growth 3Y-45.92%
ROICexgc growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score4
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.42
Cap/Depr 31.01%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.09
Altman-Z -0.15
F-Score4
WACC7.74%
ROIC/WACC0.46
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-472.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-828.57%
EPS Next Y90.49%
EPS Next 2Y44.4%
EPS Next 3Y30.64%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.81%
Revenue Next Year-1.9%
Revenue Next 2Y2.12%
Revenue Next 3Y1.98%
Revenue Next 5YN/A
EBIT growth 1Y-36.2%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year135.33%
EBIT Next 3Y55.26%
EBIT Next 5Y36.4%
FCF growth 1Y38.86%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-136.39%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%

SLEEP NUMBER CORP / SNBR Fundamental Analysis FAQ

What is the fundamental rating for SNBR stock?

ChartMill assigns a fundamental rating of 2 / 10 to SNBR.


What is the valuation status of SLEEP NUMBER CORP (SNBR) stock?

ChartMill assigns a valuation rating of 2 / 10 to SLEEP NUMBER CORP (SNBR). This can be considered as Overvalued.


Can you provide the profitability details for SLEEP NUMBER CORP?

SLEEP NUMBER CORP (SNBR) has a profitability rating of 3 / 10.


What is the expected EPS growth for SLEEP NUMBER CORP (SNBR) stock?

The Earnings per Share (EPS) of SLEEP NUMBER CORP (SNBR) is expected to grow by 90.49% in the next year.